Huntington's disease is a rare hereditary neurodegenerative pathology which usually manifests itself between the ages of 30 and 50. It is characterized by the emergence of motor, cognitive and psychiatric symptoms that alter ...
Oct 17, 2022
0
6
A study led by Johns Hopkins Medicine researchers discovered that communication among cells is altered in pregnant women who go on to develop postpartum depression (PPD) after giving birth.
Oct 4, 2022
0
54
Covid-19 vaccine maker Moderna announced Monday that it will open an mRNA vaccine manufacturing facility in the Australian city of Melbourne, a first for the southern hemisphere.
Aug 15, 2022
0
5
Florida State University researchers have developed a promising strategy for producing therapeutic particles in stem cells, work that could help patients with neurological diseases such as stroke or multiple sclerosis.
Aug 3, 2022
0
71
Inactivated and mRNA COVID-19 vaccines appear to be safe for patients treated for hypothyroidism, according to a new study being presented at ENDO 2022, the Endocrine Society's annual meeting in Atlanta, Ga. The study found ...
Jun 11, 2022
0
2
New research describes how highly proliferative leukemia cells end up becoming normal cells that no longer multiply, by changing the chemical modifications—the so-called epigenetics—of a type of its genetic material: ...
Jun 9, 2022
0
10
Prior to COVID-19 vaccines most people had never heard of messenger RNA (mRNA) used to create two of the COVID-19 vaccines on the market. However, mRNA was discovered in 1960 and since that time has been researched and used ...
Jun 9, 2022
0
1
A panel of experts convened by the US drug regulator was meeting Tuesday to consider authorizing the Novavax COVID-19 shot, a late runner in the fight against the virus that could nonetheless play a role in overcoming vaccine ...
Jun 7, 2022
0
2
A comparison of four COVID-19 vaccinations shows that messenger RNA (mRNA) vaccines from Pfizer-BioNTech and Moderna perform better against the World Health Organization's variants of concern (VOCs) than viral vector vaccines ...
May 17, 2022
1
138
While researchers are still in the early stages of development for new mRNA vaccines, global health leaders focused on the world's most neglected infectious diseases say that conversations about access should begin now.
May 11, 2022
0
17
